J&J consumer products spinoff Kenvue goes public through $3.8B IPO


The new company will operate the Fort Washington manufacturing plant that makes Tylenol, Motrin and other over-the-counter health care products.

Previous Bank failures and choppy economy threaten access to capital for local small businesses
Next Moderna turns focus to RSV vaccine race after Q1 profit beat